GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Simcere Pharmaceutical Group Ltd (HKSE:02096) » Definitions » Forward Dividend Yield %

Simcere Pharmaceutical Group (HKSE:02096) Forward Dividend Yield % : 3.04% (As of Jun. 20, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Simcere Pharmaceutical Group Forward Dividend Yield %?

As of today (2024-06-20), the Forward Annual Dividend Yield of Simcere Pharmaceutical Group is 3.04%.

As of today (2024-06-20), the Trailing Annual Dividend Yield of Simcere Pharmaceutical Group is 3.04%.

HKSE:02096's Forward Dividend Yield % is ranked better than
70.96% of 489 companies
in the Drug Manufacturers industry
Industry Median: 1.93 vs HKSE:02096: 3.04

Simcere Pharmaceutical Group's Dividends per Share for the six months ended in Dec. 2023 was HK$0.00.

During the past 12 months, Simcere Pharmaceutical Group's average Dividends Per Share Growth Rate was 6.00% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Simcere Pharmaceutical Group's Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Simcere Pharmaceutical Group's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Simcere Pharmaceutical Group's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Simcere Pharmaceutical Group's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Simcere Pharmaceutical Group's Forward Dividend Yield % falls into.



Simcere Pharmaceutical Group Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Simcere Pharmaceutical Group Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
HKD 0.1757002024-06-182024-06-202024-07-15Cash DividendannuallyHKD:HKD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Simcere Pharmaceutical Group's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=0.1757/5.77
=3.05 %

Current Share Price is HK$5.77.
Simcere Pharmaceutical Group's Dividends per Share for the forward twelve months is calculated as HK$0.1757 * 1 = HK$0.1757.

Simcere Pharmaceutical Group's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=0.1757/5.77
=3.05 %

Current Share Price is HK$5.77.
Simcere Pharmaceutical Group's Dividends per Share for the trailing twelve months (TTM) ended in Today is HK$0.1757.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Simcere Pharmaceutical Group  (HKSE:02096) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Simcere Pharmaceutical Group Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Simcere Pharmaceutical Group's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Simcere Pharmaceutical Group (HKSE:02096) Business Description

Traded in Other Exchanges
Address
No. 699-18, Xuanwu Road, Xuanwu District, Jiangsu, Nanjing, CHN, 210042
Simcere Pharmaceutical Group Ltd is engaged in the R&D, production and commercialization of pharmaceuticals focused on generic pharmaceuticals. It has a diversified product portfolio focused on therapeutic areas, including, oncology (including cell therapy), nervous system diseases, autoimmune diseases and antiinfection. The company's products include Endostar, Enweida, Iremod, Sanbexin and Others.
Executives
Wang Xi 2305 Beneficiary of a trust
Ren Jinsheng 2202 Interest of your spouse
Right Wealth Holdings Limited 2501 Other
Wang Xi 2501 Other
Simcere Investments Group Limited 2501 Other
Excel Investments Group Limited 2501 Other
Simcere Pharmaceutical Holding Limited 2501 Other
Simcere Holding Limited 2501 Other
Artking Global Limited 2501 Other
Ren Zhen 2501 Other
Ren Yong 2501 Other
Ren Weidong 2501 Other
Peng Suqin 2501 Other
P&h Holdings Group Ltd. 2501 Other
Li Shimeng 2501 Other

Simcere Pharmaceutical Group (HKSE:02096) Headlines

No Headlines